3-(2-噻吩基)苯胺 | 92057-12-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(2-噻吩基)苯胺
• 中文别名: 3-(2-噻吩)苯胺
• 英文名称: 3-(2-thienyl)aniline
• 英文别名: 3-thiophen-2-ylaniline
• CAS: 92057-12-0
• 化学式: C₁₀H₉NS
• mdl: MFCD05022493
• 分子量: 175.254
• InChiKey: YUTPSMJOCLLMBK-UHFFFAOYSA-N

物化性质

• 熔点：
  246 °C
• 沸点：
  341.6±25.0 °C(Predicted)
• 密度：
  1.196±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  54.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934999090

SDS

Name:	3-(2-Thienyl)aniline Material Safety Data Sheet
Synonym:	None Known
CAS:	92057-12-0

Section 1 - Chemical Product MSDS Name:3-(2-Thienyl)aniline Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
92057-12-0	3-(2-Thienyl)aniline	95+%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 92057-12-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Off white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 245 - 247 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H9NS
Molecular Weight: 175.25

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Will not occur.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 92057-12-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-(2-Thienyl)aniline - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 92057-12-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 92057-12-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 92057-12-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(2-噻吩基)苯胺 在 tris-(dibenzylideneacetone)dipalladium(0) 、 三氟甲磺酸三甲基硅酯 、 caesium carbonate 、 N,N-二异丙基乙胺 、 2-二环己基磷-2,4,6-三异丙基联苯 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 4.0h， 生成 2-chloro-1-(2-((3-(thiophen-2-yl)phenyl)amino)phenyl)ethanone
  参考文献：
  名称：

  保守半胱氨酸的小分子共价修饰导致TEAD·Yap蛋白-蛋白质相互作用的变构抑制。

  摘要：

  河马途径将细胞外信号协调到组织稳态和器官大小的控制上。河马信号主要调节Yap1结合并共激活TEA域（TEAD）转录因子的能力。Yap1通过一个大的扁平界面与TEAD4紧密结合，这使得小分子正构抑制剂的开发极具挑战性。在这里，我们报道了小分子TEAD·Yap抑制剂，该抑制剂可与位于TEADs独特的深层疏水性棕榈酸酯结合口袋中的保守半胱氨酸快速且选择性地形成共价键。这些化合物对TEAD4与Yap1结合的抑制作用是不可逆的，并且发生的时间更长。在哺乳动物细胞中，这些化合物与TEAD4形成共价复合物，抑制了其与Yap1的结合，阻止了其转录活性，和抑制结缔组织生长因子的表达。这些化合物抑制了患者来源的胶质母细胞瘤球体的细胞活力，使其适合用作化学探针来探索癌症中的Hippo信号传导。

  DOI：

  10.1016/j.chembiol.2018.11.010
• 作为产物：
  描述：

  2-(4-硝基苯基)噻吩 在 铁粉 、 氯化铵 作用下， 以 乙醇 为溶剂， 反应 0.5h， 以78.1%的产率得到3-(2-噻吩基)苯胺
  参考文献：
  名称：

  保守半胱氨酸的小分子共价修饰导致TEAD·Yap蛋白-蛋白质相互作用的变构抑制。

  摘要：

  河马途径将细胞外信号协调到组织稳态和器官大小的控制上。河马信号主要调节Yap1结合并共激活TEA域（TEAD）转录因子的能力。Yap1通过一个大的扁平界面与TEAD4紧密结合，这使得小分子正构抑制剂的开发极具挑战性。在这里，我们报道了小分子TEAD·Yap抑制剂，该抑制剂可与位于TEADs独特的深层疏水性棕榈酸酯结合口袋中的保守半胱氨酸快速且选择性地形成共价键。这些化合物对TEAD4与Yap1结合的抑制作用是不可逆的，并且发生的时间更长。在哺乳动物细胞中，这些化合物与TEAD4形成共价复合物，抑制了其与Yap1的结合，阻止了其转录活性，和抑制结缔组织生长因子的表达。这些化合物抑制了患者来源的胶质母细胞瘤球体的细胞活力，使其适合用作化学探针来探索癌症中的Hippo信号传导。

  DOI：

  10.1016/j.chembiol.2018.11.010

文献信息

• THIOXANTHONE RING SYSTEM DERIVATIVES
  申请人：HUANG Hsu-Shan

  公开号：US20120088810A1

  公开（公告）日：2012-04-12

  A thioxanthone ring system derivative compound is provided. The thioxanthone ring system derivative compound is represented by a formula (I): wherein X is a substituent being one selected from a group consisting of halogens, wherein R 1 is a substituent being one selected from a group consisting of sulfur and sulfur dioxide, wherein R 2 is a substituent being one selected from a group consisting of C 1 ˜C 10 alkyl group, C 3 ˜C 10 branched alkyl group, C 3 ˜C 10 cyclic alkyl group, phenyl group, phenyl alkyl group, and wherein hydrogen of phenyl group can be partially substituted by halogens, alkoxyl group, C 1 ˜C 10 alkyl group, nitro group or amine group.

  提供了一种噻二酮环系统衍生物化合物。该噻二酮环系统衍生物化合物由以下式（I）表示： 其中X是从卤素组成的一组取代基之一，其中R1是从硫和二氧化硫组成的一组取代基之一，其中R2是从C1~C10烷基，C3~C10支链烷基，C3~C10环烷基，苯基，苯基烷基中选取的一组取代基，其中苯基的氢可以部分被卤素、烷氧基、C1~C10烷基、硝基或胺基取代。
• [EN] DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS<br/>[FR] DIARYLURÉES EN TANT QUE MODULATEURS ALLOSTÉRIQUES DE CB1
  申请人：RTI INT

  公开号：WO2018209030A1

  公开（公告）日：2018-11-15

  The present invention provides novel diarylurea derivatives (compounds of formula (I)) and their uses. The compounds of the present invention are demonstrated to be allosteric modulators of the CB1 receptor, and therefore useful for the treatment of diseases and conditions mediated by CB1.

  本发明提供了新颖的二芳基脲衍生物（式（I）化合物）及其用途。本发明的化合物被证明是CB1受体的变构调节剂，因此对于治疗由CB1介导的疾病和症状是有用的。
• Design, Synthesis, and Biological Evaluation of N,N-Disubstituted-4-Arylthiazole-2-Methylamine Derivatives as Cholesteryl Ester Transfer Inhibitors
  作者：Xinran Wang、Xuehua Lin、Xuanqi Xu、Wei Li、Lijuan Hao、Chunchi Liu、Dongmei Zhao、Maosheng Cheng

  DOI：10.3390/molecules22111925

  日期：——

  Cholesteryl ester transfer protein (CETP) has been identified as a potential target for cardiovascular disease (CVD) for its important role in the reverse cholesteryl transfer (RCT) process. In our previous work, compound 5 was discovered as a moderate CETP inhibitor. The replacement of the amide linker by heterocyclic aromatics and then a series of N,N-substituted-4-arylthiazole-2-methylamine derivatives

  胆固醇酯转移蛋白 (CETP) 因其在反向胆固醇转移 (RCT) 过程中的重要作用而被确定为心血管疾病 (CVD) 的潜在靶标。在我们之前的工作中，化合物 5 被发现是一种温和的 CETP 抑制剂。利用构象限制策略设计了用杂环芳烃取代酰胺接头，然后设计了一系列 N,N-取代-4-芳基噻唑-2-甲胺衍生物。合成了 36 种化合物并评估了它们的 CETP 抑制活性。构效关系研究表明，电子供体基团取代了环 A，环 B 的 4 位上的吸电子基团对效力至关重要。在这些化合物中，化合物30表现出优异的CETP抑制活性（IC50=0.79±0。
• Radical C−N Borylation of Aromatic Amines Enabled by a Pyrylium Reagent
  作者：Yuanhong Ma、Yue Pang、Sonia Chabbra、Edward J. Reijerse、Alexander Schnegg、Jan Niski、Markus Leutzsch、Josep Cornella

  DOI：10.1002/chem.202000412

  日期：2020.3.23

  Herein, we report a radical borylation of aromatic amines through a homolytic C(sp 2 )-N bond cleavage. This method capitalizes on a simple and mild activation via a pyrylium reagent ( Sc Pyry-OTf) thus priming the amino group for reactivity. The combination of terpyridine and a diboron reagent triggers a radical reaction which cleaves the C(sp 2 )-N bond and forges a new C(sp 2 )-B bond. The unique

  在这里，我们报告通过均溶的C（sp 2）-N键裂解芳香胺的自由基硼化。该方法利用了通过吡啶试剂（Sc Pyry-OTf）进行的简单而温和的活化，从而引发了氨基的反应性。特吡啶和乙硼烷试剂的组合触发自由基反应，该反应裂解C（sp 2）-N键并形成一个新的C（sp 2）-B键。吡啶鎓中间体的独特的非平面结构为芳基的形成提供了必要的驱动力。该方法允许在电子环境中没有区别地使多种芳族胺进行硼酸酯化。
• [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS D'HISTONE DEACETYLASE
  申请人：METHYLGENE INC

  公开号：WO2005030704A1

  公开（公告）日：2005-04-07

  The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  这项发明涉及抑制组蛋白去乙酰化酶。该发明提供了抑制组蛋白去乙酰化酶酶活性的化合物和方法。该发明还提供了治疗细胞增殖性疾病和症状的组合物和方法。